Nektar Therapeutics (NKTR) Shareholder's Equity (2010 - 2026)
Nektar Therapeutics (NKTR) Shareholder's Equity (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
14.38 Mn |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
502.95 Mn |
| 10 |
Nektar Therapeutics |
1.51 Bn |
939.55 Mn |
3.16 Mn |
576.22 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
576.22 Mn |
| Dec 31, 2025 |
89.83 Mn |
| Sep 30, 2025 |
85.09 Mn |
| Jun 30, 2025 |
-24.21 Mn |
| Mar 31, 2025 |
13.74 Mn |
| Dec 31, 2024 |
60.74 Mn |
| Sep 30, 2024 |
48.88 Mn |
| Jun 30, 2024 |
79.69 Mn |
| Mar 31, 2024 |
126.71 Mn |
| Dec 31, 2023 |
130.99 Mn |
| Sep 30, 2023 |
159.37 Mn |
| Jun 30, 2023 |
196.96 Mn |
| Mar 31, 2023 |
240.87 Mn |
| Dec 31, 2022 |
366.64 Mn |
| Sep 30, 2022 |
412.22 Mn |
| Jun 30, 2022 |
458.73 Mn |
| Mar 31, 2022 |
607.89 Mn |
| Dec 31, 2021 |
679.51 Mn |
| Sep 30, 2021 |
801.54 Mn |
| Jun 30, 2021 |
904.98 Mn |
